2025’s key multi-omics webinars and podcasts featuring VUGENE experts

Looking to dive deeper into multi-omics integration?

Grab a coffee and catch up on some of our key 2025 podcast appearances and webinars featuring Juozas Gordevičius, PhD, and Ingrida Olendraitė, PhD.

 

Thought Leadership on Multi-omics

 

WATCH – Unlocking Cellular Secrets with Multi-Omics (The Pharma Navigator)

WATCH – Multi-omics and its potential in advancing future drug development (Careers in Discovery, Singular: Building Brilliant Biotechs)

WATCH – Unraveling disease mechanics through multi-omic integration: Insights from metabolomics and beyond (Multi-omics – The medicine of tomorrow at your fingertips, biocrates life sciences gmbh)

WATCH – Multi-omic data analysis and interpretation for human disease (Metabolomics India 2025, biocrates life sciences gmbh)

 

The Future of Biotech and Healthcare in Lithuania

 

WATCH – Lithuanian Life Sciences Sector 2025 (Inovacijų agentūra)

WATCH – Living longer, but getting sick earlier: What will our senior years look like? (Ateities architektai, Inovacijų agentūra)

WATCH – Treatments tailored to our DNA: What difference would it make for patients? (Ateities architektai, Inovacijų agentūra)

 

Cover photo credits: sripfoto / Adobe Stock

Similar Resources

Juozas Gordevičius
News
October 5, 2026

VUGENE Appoints Founder Juozas Gordevičius, PhD, as Chief Executive Officer and Edita Karosienė, PhD, as Chief Scientific Officer

Leadership appointments position VUGENE for accelerated product development, customer acquisition, and international growth VUGENE, an AI-driven multi-omics interpretation and translational science company, today announced the appointment of Founder Juozas Gordevičius, ...

kidney cancer
News
October 1, 2026

VUGENE Develops Multi-Omics Platform for Kidney Cancer Diagnostics and Establishes a Spin-Off Company

VUGENE, in collaboration with Vilnius University and Vilnius University Hospital Santaros Klinikos, has announced the results of its research and experimental development (R&D) project, “Development of a Clinical Multi-Omics Platform ...